Medical Device Design Transfer Services & Manufacturing Readiness
Design transfer is the move from a verified prototype to volume production. It is where most medical device programs lose time and money.
Our Manufacturing Readiness Assessment is an independent review that finds what will break during that move, and shows you how to prevent it, before you cut tooling.
We work with medical device companies across North America and worldwide.
Inertia Group Inc. (Toronto) is certified by Intertek to ISO 13485:2016 for the contract design, development, and manufacture of active and non-active medical devices. Our Guangzhou facility is certified to ISO 13485:2016 for medical device manufacturing.
What design transfer is, and what the FDA and ISO 13485 require
Design transfer is the point where a design that passed verification becomes a device a factory can build repeatably. Both the FDA’s Quality Management System Regulation and ISO 13485’s design and development transfer clause require it, and both require the same proof: that the device you designed is the one your factory will actually build.
Three record sets carry that proof.
- The design and development file records how the design was developed and verified.
- The medical device file holds the production specifications: the bill of materials, the work instructions, the drawings and the acceptance criteria.
- The production and traceability records show what was actually built, for a given batch.
These record names follow the FDA’s Quality Management System Regulation, in effect since February 2, 2026, which incorporates ISO 13485:2016 by reference. Under it the Design History File (DHF) became the Design and Development File (ISO 13485 clause 7.3.10), the Device Master Record became the Medical Device File (clause 4.2.3), and device history is kept as production and traceability records (clauses 7.5.1 and 7.5.9). Source: U.S. FDA, Quality Management System Regulation.
Design transfer is complete when the medical device file is correct, and a factory can build to it without asking your engineers what was meant.
Most programs get the paperwork finished and still fail here. The records can be complete and still describe a device that cannot be built at volume.
An independent medical device design transfer review from a firm that both designs and manufactures
Most firms that work in design transfer are trying to win the build. A design studio hands your program off before production risk shows up, and a contract manufacturer inherits a design it did not create, then discovers the problems during tooling.
We are not bidding for your build. The assessment is the whole job, and it ends with the report.
We design and manufacture regulated hardware ourselves. The people reviewing your program have lived on both sides of the handoff, so they see what breaks at the seam between design and production, which is where most transfer failures live.
What a manufacturing readiness assessment finds before tooling is cut
In the transfer programs we are called into, the failures were visible months in advance. A manufacturing readiness assessment finds them while change is still cheap, before tooling locks them in.
By this point your device works. Verification is closing out, the business case is approved, and the pressure is schedule: move from a working prototype to production and hit the launch window. That move is a different discipline from the design work that got you here, and it is where most of the risk sits.
Most product failures accumulate in the gap between design and the production line, and by default no one inside the company owns that gap. The team is heads-down building the product, and a design team is not positioned to judge its own readiness independently. That independent judgment is what the assessment provides, against a fixed list of questions asked before tooling is committed.
Most companies do not measure the gap either. An MDIC and Xavier Health quality-metrics working group that included FDA officials found that organizations do not track how often development fails during device transfer, so they cannot tell whether their development process is improving.
Why medical device design transfers go wrong, and what it costs
Across more than two decades of regulated hardware programs, the transfer failures we are called in to fix almost never trace back to a technical mistake.
They trace back to a decision made in isolation, usually more than a year earlier and usually reasonable at the time: a tolerance chosen without process capability data, a connector selected without a second source, or a test plan written before the production line existed.
The fix is a working feedback loop between the people who design and the people who build.
Each party is competent. The risk lives in the seams between them, and by default the only organization accountable for the seams is you.
A design transfer readiness checklist, nine questions to ask before you cut tooling
Nobody owns the gap between a finished design and a working production line. These are the nine questions we ask before tooling is cut.
| 1 | Could a factory you do not own build it, without your engineers on the floor? | Industrial base |
| 2 | Was DFM done at real volumes, or at nominal ones? | Design maturity |
| 3 | Do you know your unit cost at volume? | Production cost |
| 4 | Can your vendors hold tolerance at 10,000 units, the way they did at 50? | Materials and suppliers |
| 5 | Are IQ, OQ and PQ done? Is PPQ booked? | Process control |
| 6 | Does your QMS cover the transfer, or stop at the handoff? | Quality management |
| 7 | Could someone build it from your work instructions alone? | Workforce |
| 8 | Is this production tooling, or prototype tooling? | Facilities and tooling |
| 9 | Is there a build schedule, with materials planned against it? | Manufacturing planning |
The Manufacturing Readiness Assessment, a fixed-scope design transfer review
The Manufacturing Readiness Assessment is a fixed-scope, senior-led design transfer review that answers one question: what is most at risk to fail at scale, and how do we prevent it?
- Manufacturability: we review your design for manufacturing and assembly against your actual production volumes and processes.
- Test coverage: we assess your test coverage and calibration for the gaps that let defects through.
- Documentation: we review your bill of materials, approved vendor list, work instructions, and travelers to confirm they say what your engineers think they say.
- Supply chain: we assess your suppliers’ capability and lead times against what production will demand.
- Process and equipment readiness: we check that someone has actually planned your process validation and IQ, OQ, and PQ.
- Hidden scale risks: we identify the blockers that would stall your ramp and rank them by the cost of leaving them unaddressed.
What you receive is a prioritized risk report and an actionable readiness roadmap, with the reasoning behind every finding written down, so your team can see how we got there.
The same work group points to a simple test. If the design work was solid, little should need changing when the device moves into production. The number of changes during transfer tells you how good the development really was.
The assessment is a complete deliverable on its own. What comes next depends on what we find, not on what we hope to sell you.
Do you need an independent readiness review if you already have a design firm and a contract manufacturer?
Your design firm and your contract manufacturer each own part of the path to production, and neither is accountable for the seam between them. An independent readiness review checks that seam before tooling is cut.
| Role | What it owns | Where it stops |
|---|---|---|
| A design firm | A working, verified prototype | Hands off before production risk appears |
| A contract manufacturer | Building to the documentation it is given | Does not vet whether that documentation is right |
| An independent readiness review | The seam between design and production | Advises; your team acts on the findings |
Why medical device companies choose Inertia for design transfer
We design and manufacture regulated devices ourselves, so we assess your transfer from both sides of the handoff, not just the design side.
Strategy, engineering, and manufacturing are interconnected here, one decision system rather than a relay between separate firms. By the time a design reaches transfer, production reality is already built into it.
We live on both sides of that seam, so design intent survives the transfer instead of being reinterpreted under schedule and cost pressure, and what we flag holds up on a real production floor.
Explore our work
Common questions about medical device design transfer
What is design transfer for a medical device?
+
Design transfer for a medical device is the move from a verified prototype to volume production, in which the design is translated into production specifications a factory can build to repeatably.
A working prototype proves the science. Production proves you can build the device repeatably, at volume, yield, and cost, under design controls.
A manufacturing readiness assessment tells you whether your design, documentation, suppliers, and test strategy are ready for that move before you commit to tooling.
Why are there FDA requirements for design transfer?
+
Because a device that was designed correctly can still be built incorrectly, and the patient carries that risk.
The FDA’s Quality Management System Regulation requires that the approved design is correctly translated into production specifications. ISO 13485 carries the same requirement in its design and development transfer clause. Both exist so the device leaving the factory matches the device that was verified.
What is a device master record?
+
The Device Master Record (DMR) is the set of production specifications for a finished device. Under the FDA's current Quality Management System Regulation, this is now called the medical device file. It holds the bill of materials, the approved vendor list, the drawings, the work instructions, the process specifications and the acceptance criteria. Design transfer is the process of building it correctly, and a transfer is not finished until a factory can build from it without asking your engineers what was meant.
What is DFM in medical devices?
+
Design for Manufacturing (DFM) is the practice of shaping a design so it can be built efficiently with the processes, tolerances and volumes you actually intend to use.
In medical devices it carries extra weight, because a change made after design freeze has to move through design controls, risk management and revalidation. Design for Manufacturing (DFM) done at nominal volumes and then scaled is one of the most common causes of transfer failure.
Inertia runs design for manufacturing as a standalone service.
What is a manufacturing readiness assessment for a medical device?
+
A manufacturing readiness assessment for a medical device is an independent review that finds what will break when the device moves from a verified prototype to volume production, and ranks those risks by what they cost to fix later. The deliverable is a written risk report and readiness roadmap. It is a complete engagement on its own, not a lead-in to a build.
Is a manufacturing readiness assessment the same as a DFM review?
+
No. A DFM review checks whether a design can be manufactured efficiently with the processes you intend to use. A manufacturing readiness assessment includes that DFM review and adds test coverage, documentation, supplier capability, process validation, and ranked scale risks.
A DFM review tells you whether the part can be made. A readiness assessment tells you whether the program is ready to move to production.
How do you know a medical device is ready for design transfer?
+
A medical device is ready for design transfer when the verified design can be built at target volume, yield, and cost, and the people and records to do so are in place. In practice that means: the design and development file (formerly the Design History File (DHF)) is complete; the documentation package of bill of materials, approved vendor list, work instructions, and travelers says what your engineers think it says; suppliers can hold tolerance at production volumes; and process validation through IQ, OQ, PQ, and PPQ is planned, along with your test coverage.
A readiness assessment scores you against that checklist and ranks the gaps by the cost of leaving them unaddressed.
Should you use one firm for both medical device design and manufacturing, or separate firms?
+
One firm that both designs and manufactures can give you a readiness review from people who have lived on both sides of the handoff, which is where most transfer failures hide.
Separate firms each own part of the path and neither owns the seam between them, where fixes get expensive once tooling is cut.
An independent assessment from a firm that does both catches those seam failures before you commit to tooling.
How is a manufacturing readiness assessment different from what a contract manufacturer does?
+
A manufacturing readiness assessment is an independent review of whether a medical device is ready for production. A contract manufacturer is hired to build it. The difference is incentive: a reviewer with no stake in winning the build has no reason to overlook a problem that would surface during tooling, when fixes are most expensive.
When should you run a manufacturing readiness assessment?
+
Run a manufacturing readiness assessment when your product works and verification is approaching or behind you, and before tooling is cut.
The earlier a structural gap is found, the less it costs to close, because after tooling a findable problem becomes a six-figure problem with a schedule attached.
Is a manufacturing readiness assessment right for your program?
+
The assessment fits a program where the device works and design verification is approaching or complete, and where tooling has not yet been cut.
It is built for regulated hardware, covering Class I and Class II devices under the FDA's classification.
The assessment is run for medical device companies across North America and worldwide, under ISO 13485 certification, operating a quality system aligned to the FDA's QMSR.